Concepedia

Péter Faludi

PF

3

Publications

3.4K

Citations

3

H-Index

2009

Active since

Affiliations

Eli Lilly (United States)(Current)

McMaster University

Hamilton Health Sciences

Polish Academy of Sciences

Universidad De Santander

Péter Faludi is an author at Eli Lilly (United States) specializing in medicine, diabetes, and metabolic syndrome.

Top concepts

Publications per year

2009–2019

3

Publications

3

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

The effect of exenatide re-exposure on safety and efficacy

Péter Faludi, Robert G. Brodows, Jude Burger et al. · Peptides · 2009 · 24 citations

, , +5

Rows per page

1–3 of 3